Neuromuscular Diseases in Children
9
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Gamification Effects on the 6-Minute Walk Test in Children
Virtual Reality Impact on Powered Mobility: a Feasibility Study
CIMR Neuromuscular Research Biobank
Mechanical Insufflator/Exsufflator Technique in Children With Neuromuscular Disease
Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular Diseases
Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease
Mechanical Insufflation -Exsufflation in Children With NMD and Weak Cough
Study of the Correlation Between Muscle Oxygenation and Motor Function in Children With Neuromuscular Disease.
Muscle Spasticity Reduction in Children With Cerebral Palsy by Means of Hippotherapy